Fibrinogen
Fibrinogen |
WikiDoc Resources for Fibrinogen |
Articles |
---|
Most recent articles on Fibrinogen |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Fibrinogen at Clinical Trials.gov Clinical Trials on Fibrinogen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Fibrinogen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Fibrinogen Discussion groups on Fibrinogen Patient Handouts on Fibrinogen Directions to Hospitals Treating Fibrinogen Risk calculators and risk factors for Fibrinogen
|
Healthcare Provider Resources |
Causes & Risk Factors for Fibrinogen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
- Fibrinogen is a blood clotting factor that is formed in the liver
- Fibrinogen is also an acute-phase protein
- Reference range: 180-350 mg/dl
Differential Diagnosis
In alphabetical order. [1] [2]
Decreased
- Ascites
- Asparaginase therapy
- Cachexia
- Congenital afibrinogenemia
- Disseminated Intravascular Coagulation (DIC)
- Hemodilution
- Hereditary afibrinogenemia or hypofibrinogenemia
- Liver failure
- Multiple Myeloma
- Pancreatic carcinoma
- Primary or secondary fibrinolysis
- Prostate carcinoma
- rPA
- Sepsis
- Shock
- Streptokinase
- T-PA
- TNK
- Urokinase
Increased
- Acute infection
- Diabetes Mellitus
- Drugs
- Myocardial Infarction
- Postoperative
- Pregnancy
- Tumor
References
Acknowledgements
The content on this page was first contributed by Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
List of contributors:
Suggested Reading and Key General References
Suggested Links and Web Resources
For Patients